Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide.

The salient pathological feature of Alzheimer disease (AD) is the presence of a high density of amyloid plaques in the brain tissue of victims. The plaques are predominantly composed of human beta-amyloid peptide (beta A4), a 40-mer whose neurotoxicity is related to its aggregation. Radioiodinated h...

Deskribapen osoa

Gorde:

Xehetasun bibliografikoak
Argitaratua izan da:	Proc Natl Acad Sci U S A
Egile Nagusiak:	Maggio, J E, Stimson, E R, Ghilardi, J R, Allen, C J, Dahl, C E, Whitcomb, D C, Vigna, S R, Vinters, H V, Labenski, M E, Mantyh, P W
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	National Academy of Sciences 1992
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC49312/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1608956/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.89.12.5462
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide.

Antzeko izenburuak